Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Scaling Clinical Diagnostic Testing to the Masses (Part 1)

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of  those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who could really use it. So what are some the things a company can do to make clinical diagnostic testing more accessible for everyone? How can an important medical test be affordable to all?

On this episode of Health & Life Sciences at the Edge, host Michelle Dawn Mooney talks with Intel Head of Business Innovation and Life Science Specialist Blake Harlan and SiPhox Chief Product Officer Mike Dubrovsky about clinical diagnostic testing, the way it is used, and the way its use can be improved.

“Clinical diagnostic testing is actually a major part of the [healthcare] system,” says Dubrovsky. “Seventy percent of all medical decisions require diagnostic tests. However, the way that it’s done now is very reactive, so the whole system is based on first the patient having symptoms and then they’re put through a series of tests to try to resolve the problem.” Harlan and Dubrovsky further mention how it’s easy for those in higher income brackets to get tested more often, as those types of tests cost much more than the ones for reactive patients who are presently experiencing symptoms.

“The way the healthcare system works now is it’s really set up to, for the person, once they get sick, to deal with that” says Dubrovsky. He points out how the system is primarily designed to treat reactive care. “The problem is that there is a massive rise in healthcare costs, accompanied with actually a decrease in life expectancy, at least in America”, where six out of ten Americans have at least one chronic disease. In a country that spends so much on healthcare research, Harlan and Dubrovsky think the country needs to shift its thinking and policies when it comes to the health of its citizens.

Learn more about network operations center solutions by connecting with Blake Harlan and Mike Dubrovsky on LinkedIn or visiting SiPhox or Intel Health and Life Sciences.

Subscribe to this channel on Apple PodcastsSpotify, and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison serves as the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston. The article focuses on her strategic role and initiatives in analytics within the organization. The context is in the healthcare industry, with insights pertaining to Texas.

  • 01Jessica Davison is the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston.
  • 02The article discusses strategic roles and analytics initiatives within healthcare.
  • 03The focus is on the healthcare industry in Texas.

Aug 25, 2026

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Hospitals are alerting patients about phishing scams involving Epic’s MyChart, as these scams impersonate the patient portal to deceive users. The concern grows as CMS encourages healthcare innovation and interoperability. As a response, healthcare teams are treating portal identity as a vital security frontier.

  • 01Hospitals are experiencing phishing scams that mimic Epic’s MyChart portal.
  • 02The CMS continues to push for industry-led pledges toward healthcare interoperability.
  • 03Patient portal identity is being prioritized as a critical aspect of cybersecurity.

Aug 25, 2026

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis has appointed a new Chief Product Officer (CPO) and promoted its first Chief Revenue Officer (CRO), following a successful $40 million Series C funding round and a fourfold increase in revenue. This move underscores a shift among AI RCM vendors, like Adonis, from pilot projects to platform-based operating models. This transition is expected to result in more structured product roadmaps and a strong emphasis on value demonstration for health systems.

  • 01Adonis appointed a new CPO and promoted its first CRO.
  • 02The company achieved a $40 million Series C funding and a fourfold revenue increase.
  • 03AI RCM vendors are moving from pilot projects to platform operating models.

Aug 22, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512